Transforming growth factor-beta and 1,25-dihydroxyvitamin D3 induce 5-lipoxygenase activity during myeloid cell maturation.
Steinhilber
D
D
Pharmaceutical Institute, University of Tübingen, F.R.G.
Brungs
M
M
Rådmark
O
O
Samuelsson
B
B
D001094:Arachidonate 5-Lipoxygenase / Q000096:biosynthesis*; D002117:Calcitriol / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004790:Enzyme Induction; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute; D016133:Polymerase Chain Reaction; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D014212:Tretinoin / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D016212:Transforming Growth Factor beta; D014212:Tretinoin; D001094:Arachidonate 5-Lipoxygenase; D002117:Calcitriol; D004121:Dimethyl Sulfoxide